Tony Wood übernimmt im August 2022 die volle Verantwortung für die F&E von GSK Hal Barron wechselt im August 2022 vom CSO zu einem GSK Non-Executive Director mit zusätzlichen Verantwortlichkeiten zur Unterstützung von Forschung und Entwicklung (PRESSEMITTEILUNG) LONDON, 19-Jan-2022 — … Read the full press release
Posted in Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, biotechnologie, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Ernennung, F&E, Forschung und Entwicklung, Genome Research, Genomik, GlaxoSmithKline plc, GSK, Immunologie, Imperial College, Infektionskrankheiten, Jemperli, künstliche Intelligenz, maschinelles Lernen, Medikamente, Nucala, Onkologie, Pfizer, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
Dupixent is the first and only medicine to demonstrate positive Phase 3 results in prurigo nodularis, confirming the potential benefit of targeting IL-4 and IL-13, central drivers of type 2 inflammation, to address itch and skin lesions Data confirm results … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged asthma, atopic dermatitis, CRSwNP, dermatological diseases, dupilumab, Dupixent, extreme itch, George D. Yancopoulos, inflammatory skin disease, Naimish Patel, nodules, persistent itch, prurigo nodularis, Regeneron, respiratory diseases, skin diseases, skin lesions, unbearable itch
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, appointment, artificial-intelligence, biotechnology, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Genome Research, genomics, GlaxoSmithKline plc, GSK, immunology, Imperial College, infectious disease, Jemperli, Machine Learning, medicines, Nucala®, oncology, Pfizer, R&D, research and development, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
Joint press release by WACKER and Biosyntia (PRESS RELEASE) MUNICH/ COPENHAGEN, 11-Jan-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, has announced it will partner with Biosyntia, a biotech startup within synthetic biology and metabolic engineering … Read the full press release
Posted in Business, Chemicals, Denmark, Germany, News, Pharma & Biotech
Tagged Biosyntia, Biotech, biotin, coenzyme, dietary supplement, EFSA, European Food Safety Authority, fermentation-based biotin, hair, macronutrient metabolisms, Martin Plambech, nervous system, nutraceutical ingredients, skin, Susanne Leonhartsberger, sustainable fermentation, vitamin B7, vitamins, WACKER Group
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged Bayer AG, Cas enzymes, Cas14, Casɸ, cell therapy, CRISPR, Dr. Imke Meyer, Dr. Peter Nell, gene augmentation, gene editing, gene therapy, gene-editing technology, gene-editing therapies, iPSC, liver diseases, Mammoth Biosciences, Mohana Ray, pluripotent stem cell, Stefan Oelrich, vivo projects
Topline results from the randomized EMPATHY Part A study in acute COVID-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days The secondary … Read the full press release
Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to non-invasive prenatal testing (NIPT), while Actome partnership designed to enable for the first time protein analysis using digital PCR technology … Read the full press release
Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition (PRESS RELEASE) CAMBRIDGE, 7-Jan-2022 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced … Read the full press release
Posted in Healthcare, Marketing, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Alexion, amyloid fibril deposits, amyloidosis, AstraZeneca, ATTR-CM, cardiomyopathies, Heart, heart failure, human monoclonal antibody, licence agreement, Marc Dunoyer, misfolded transthyretin, Neurimmune AG, NI006, rare disease, transthyretin amyloid cardiomyopathy
(PRESS RELEASE) CAMBRIDGE, 5-Jan-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced the completion of the transfer of its global rights to Eklira (aclidinium bromide), popular as Tudorza in the US, and Duaklir … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Aclidinium bromide, Adrian Kemp, Almirall S.A., AstraZeneca, biopharmaceutical, Bretaris, Brimica, Chronic obstructive pulmonary disease, Covis Pharma, Covis Pharma Group, dry powder inhaler, Duaklir, Eklira, formoterol, Genuair, inhaled respiratory medicines, LABA, LAMA, muscarinic antagonist, Tudorza
(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. This … Read the full press release
Posted in Education, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged 6th annual EU Patients as Partners, AbbVie, Biotech, clinical development, clinical research, clinical trial, clinical trials, Conference, Conference Forum, data, dct, decentralized, DNA, EMD Serono, Gilead Sciences, GSK, INNOVATION, Ipsen, Janssen, Johnson & Johnson, Medicines Development, Merck KGaA, Michaela Dinboeck, MS trial, Noema Pharma, Novartis, Parkinsons disease, patient engagement, patient input, Patient Voice, patients, Patients as Partners Europe, Pfizer, pharma, Pharmaceutical, Pierre Fabre, Regeneron, Takeda, UCB
(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England, United Kingdom, has announced that a research that it led together with Rigel Pharmaceuticals (NASDAQ: RIGL), a biotech firm dedicated … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AMPK, anxiety, blood sugar levels, blood sugars, brain-pancreas, coma, confusion, Conor McKeever, Diabetes, Diabetes UK, dizziness, Dr Ana Cruz, Dr Craig Beall, Dr Lucy Chambers, Endocrinology, Frontiers in Endocrinology, glucose-sensing neurons, GT1-7 cells, hormonal defence systems, Hunger, hyperglycaemia, hypoglycaemia, hypos, insulin, JDRF, loss of consciousness, low blood sugar, metformin, palpitations, R481, RESEARCH, Rigel Pharmaceuticals, sweating, University of Exeter
(PRESS RELEASE) AMSTERDAM, 14-Dec-2021 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has announced the acquisition of Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. The acquired … Read the full press release
Posted in Business, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, advanced venous stent, Bruce Shook, Chris Landon, deep venous disease, diagnostic, health technology, Intact Vascular, intravascular ultrasound, IVUS catheters, live 2D/3D interventional imaging, medical technology, PAD, peripheral artery disease, peripheral atherectomy devices, peripheral therapy devices, peripheral vascular, peripheral vascular devices, Royal Philips, therapeutic devices, venous imaging, Vesper Medical, Vesper Medical Inc
People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged American Society of Hematology, ASH, bleeding, blood clotting, blood disease, Chugai, Chugai Pharmaceutical, diagnostics, emicizumab, Genentech, haemophilia, Haemophilia A, HAVEN 6, Hemlibra®, Levi Garraway, pharmaceuticals, pharmacodynamics, pharmacokinetics, phase III HAVEN 6 study, prophylactic, Roche
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged advance sequencing technologies, AVENIO Edge System, diagnostic solutions, diagnostics, In Vitro Diagnostics, integrated sequencing, IVD, next-generation sequencing, NGS, Roche, sequencing library preparation, Thomas Schinecker
An innovative solution seamlessly integrates trade finance, cash management and FX needs, into a single, streamlined and automated workflow (PRESS RELEASE) FRANKFURT AM MAIN, 2-Dec-2021 — /EuropaWire/ — Deutsche Bank (ETR: DBK), Germany’s leading multinational investment bank and financial services … Read the full press release
Posted in Artificial Intelligence (AI), Banks, Financial, Germany, Investment, News, Pharma & Biotech, Technology
Tagged AI, analytics, artificial-intelligence, automation, Deutsche Bank, FX execution, FX risk, Jörg Bermüller, liquidity management, Merck India, Rajesh Thakur, Receivables Matching, regulatory validations, risk management, treasury, treasury workflow
Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release
Posted in Austria, Business, France, Healthcare, News, Pharma & Biotech
Tagged acne, acne vulgaris, acquisition, antigens, biotechnology, Cutibacterium acnes bacterium, microbiome, mRNA, ORI-001, Origimm Biotechnology GmbH, Sanofi, Sanya Selak, skin disease, skin immunology, skin microbiome, Thomas Triomphe, virulent skin microbiome
(PRESS RELEASE) HELSINKI, 30-Nov-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland, and University Hospital Helsinki, Finland’s largest provider of healthcare services, have announced that their researchers have developed a method to … Read the full press release
Posted in Education, Finland, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged autologous cells, autologous pluripotent stem cells, Biomedicum Helsinki Stem Cell Center, corrected stem cells, CRISPR-Cas9, DNA errors, gene alterations, gene editing, gene scissors, genetic alterations, genetic diseases, immunological challenges, iPSCs, Joonas Sokka, Kirmo Wartiovaara, Ras Trokovic, researchers, Rocío Maldonado, Sami Jalil, skin biopsy, Stem cells, therapies, Timo Keskinen, Timo Otonkoski, University Hospital Helsinki, University of Helsinki
EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction Icon Group is Australia’s largest vertically integrated cancer … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisition, Australia, Blikk, cancer care, cancer clinical trials, cancer drug infusions, cancer patients, cancer treatment, compounding, decentralisation, Deloitte, diagnostic imaging provider, digitalization, EQT, EQT Infrastructure, EQT Infrastructure V, Goldman Sachs Asset Management, healthcare sector, Herbert Smith Freehills, I-MED, Icon Group, integrated cancer-care operator, Integrated Clinical Oncology Network, investment, Jim Kelly, Ken Wong, Mark Middleton, medical oncology, Meine Radiologie Holding, Morgan Stanley, nuclear medicine, oncology, Pagoda Investment Advisors, pharmacy, PwC, QIC Private Capital Pty Ltd, Radiation Oncology, radiology, radiotherapy, Stephanie Hui
(PRESS RELEASE) HOERSHOLM, Denmark, 16-Nov-2021 — /EuropaWire/ — Chr. Hansen (CPH: CHR), a Danish bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries, has announced the latest addition to its sugar reduction portfolio for … Read the full press release
Posted in Agriculture, Denmark, Food & Beverage, News, Pharma & Biotech, Science
Tagged Chr. Hansen, cultures, dairy producers, enzymatic activity, enzymes, fermentation, fresh dairy, glucose, Ha-Lactase™, Katarzyna McCall, lactose, low-sugar, NOLA® Fit, reduce lactose, sugar reduction, SWEETY®, SWEETY® Y-3, YoFlex®, yogurt
(PRESS RELEASE) KFAR SABA, Israel, 9-Nov-2021 — /EuropaWire/ — Origami, a leading provider of no-code business process automation software for Medical Device and other industries, and citoQualis, a regulatory and business advisory leader for EU Medical Device companies, are announcing … Read the full press release
Posted in Healthcare, News, Pharma & Biotech
Tagged Amanda Brewster, business process automation, cGMP, citoQualis, EU MDR, EU regulatory, EU regulatory updates, GMP, GROWTH, ISO 13485, ISO 9001, IVDR, Life Science, Market Access, MDSAP, medical device, origami, patient safety, Pharmaceutical, QMS, Quality Management, Regulation (EU) 2017/745, Regulations, regulatory compliance, supply chain, US, Wolfgang Werner, Yaniv Shimony
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?